Clinical Implications of Imipramine Plasma Levels for Depressive Illness
- 1 February 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 34 (2), 197-204
- https://doi.org/10.1001/archpsyc.1977.01770140087010
Abstract
From JAMA Psychiatry — Clinical Implications of Imipramine Plasma Levels for Depressive IllnessKeywords
This publication has 14 references indexed in Scilit:
- Plasma levels and antidepressive effect of imipramineClinical Pharmacology & Therapeutics, 1976
- Biogenic Amines and DepressionArchives of General Psychiatry, 1975
- Depression, Delusions, and Drug ResponseAmerican Journal of Psychiatry, 1975
- Plasma levels and tricyclic antidepressantsClinical Pharmacology & Therapeutics, 1974
- The Clinical Pharmacology of ImipramineArchives of General Psychiatry, 1973
- PLASMA-NORTRIPTYLINE LEVELS IN ENDOGENOUS DEPRESSIONThe Lancet, 1973
- Unipolar and Bipolar Affective IllnessArchives of General Psychiatry, 1971
- Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compoundsLife Sciences, 1967
- Plasma Levels of Imipramine and Desmethylimipramine during TherapyThe British Journal of Psychiatry, 1967
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960